Eosinophilia-Myalgia Syndrome
"Eosinophilia-Myalgia Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
| Descriptor ID |
D016603
|
| MeSH Number(s) |
C05.651.290 C10.668.491.387 C15.378.553.231.335
|
| Concept/Terms |
Eosinophilia-Myalgia Syndrome- Eosinophilia-Myalgia Syndrome
- Eosinophilia Myalgia Syndrome
- Eosinophilia-Myalgia Syndromes
- Syndrome, Eosinophilia-Myalgia
- Syndromes, Eosinophilia-Myalgia
Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related- Eosinophilia-Myalgia Syndrome, L-Tryptophan-Related
- Eosinophilia-Myalgia Syndromes, L-Tryptophan-Related
- L-Tryptophan-Related Eosinophilia-Myalgia Syndromes
- Syndrome, L-Tryptophan-Related Eosinophilia-Myalgia
- Syndromes, L-Tryptophan-Related Eosinophilia-Myalgia
- Syndrome, Eosinophilia-Myalgia, L-Tryptophan-Related
- L-Tryptophan-Related Eosinophilia-Myalgia Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Eosinophilia-Myalgia Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Eosinophilia-Myalgia Syndrome".
This graph shows the total number of publications written about "Eosinophilia-Myalgia Syndrome" by people in this website by year, and whether "Eosinophilia-Myalgia Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 0 | 3 |
| 1995 | 3 | 0 | 3 |
| 1996 | 3 | 0 | 3 |
| 1997 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Eosinophilia-Myalgia Syndrome" by people in Profiles.
-
Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms. Arthritis Rheum. 2009 Oct 15; 61(10):1305-11.
-
Panniculitis. Dermatol Clin. 2002 Jul; 20(3):421-33, vi.
-
Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome. J Rheumatol. 1997 Jan; 24(1):69-72.
-
Increased activity of the alpha 1(I) procollagen promoter in skin fibroblasts from patients with chronic eosinophilia-myalgia syndrome. Int J Biochem Cell Biol. 1997 Jan; 29(1):135-41.
-
Pathophysiology of the eosinophilia-myalgia syndrome. J Rheumatol Suppl. 1996 Oct; 46:26-36.
-
Cognitive deficits in a murine model of the eosinophilia-myalgia syndrome: a preliminary report. Neurotoxicol Teratol. 1996 Sep-Oct; 18(5):595-601.
-
A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome. Proc Assoc Am Physicians. 1996 Jul; 108(4):315-22.
-
Eosinophilia-myalgia syndrome: a long-term follow-up study. South Med J. 1995 Sep; 88(9):953-8.
-
The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Ann Intern Med. 1995 Jun 01; 122(11):851-5.
-
The eosinophilia-myalgia syndrome--guidelines for patient care. J Rheumatol. 1995 Jan; 22(1):161-3.